Medical/Pharmaceuticals

Winner Medical Celebrates 30th Anniversary with Continued Focus on Sustainable Development

SHENZHEN, China, Sept. 10, 2021 /PRNewswire/ -- Winner Medical Co., Ltd. (300888.SZ), a leading manufacturer of high-quality medical and consumer products, celebrates its 30th anniversary this year alongside the release of its first annual corporate social responsibility report which highlights i...

2021-09-10 14:44 6893

Mindray Brings Increased Clinical Efficiency and Diagnostic Confidence to Medical Industry with New TE9 POC Ultrasound System

SHENZHEN, China, Sept. 10, 2021 /PRNewswire/ -- Mindray (SZSE: 300760), a global leading developer and provider of medical devices and solutions, has today announced the launch of its latest Point-of-Care (POC) ultrasound system, the TE9, featuring a larger screen for enhanced viewing, intelligen...

2021-09-10 13:00 3569

DiaCarta Receives CE/IVD for its New COVID 19 Screening Test that Identifies Delta Plus and New Variants

PLEASANTON, Calif., Sept. 10, 2021 /PRNewswire/ -- DiaCarta Inc., a precision molecular diagnostics company and leading developer of novel oncology tests using liquid biopsy today announced that its new QuantiVirus™ SARS-CoV-2 Variant Detection Test received the CE/IVD marking and therefore, can ...

2021-09-10 02:02 3111

Yuyu Pharma Receives ISO 37001 Anti-Bribery Management System Certification

SEOUL, South Korea, Sept. 9, 2021 /PRNewswire/ -- Yuyu Pharma (KRX: 000220) received the ISO 37001 Anti-Bribery Management System (ABMS) certification from the British Standards Institution (BSI) inAugust 2021. Chief Executive Officer Robert Wonsang Yu said "we believe that the certification is a...

2021-09-09 21:00 3419

Medigate and CrowdStrike to Provide Healthcare Organizations with Unified Endpoint Security for Medical IoT Devices

Integration enables comprehensive visibility, enhanced risk management and security enforcement BROOKLYN, N.Y., Sept. 9, 2021 /PRNewswire/ -- Medigate, healthcare's Best in KLAS IoT Security Provider, today announced it has partnered with CrowdStrike, a leading provider of cloud-delivered e...

2021-09-09 21:00 2446

Medigate and CrowdStrike to Provide Healthcare Organizations with Unified Endpoint Security for Medical IoT Devices

Integration enables comprehensive visibility, enhanced risk management and security enforcement BROOKLYN, N.Y., Sept. 9, 2021 /PRNewswire/ -- Medigate, healthcare's Best in KLAS IoT Security Provider, today announced it has partnered with CrowdStrike, a leading provider of cloud-delivered e...

2021-09-09 20:51 2192

Sofwave Medical Appoints Assaf Korner as Chief Financial Officer

TUSTIN, Calif., Sept. 9, 2021 /PRNewswire/ -- Sofwave Medical LTD (TASE: SOFW) ("Sofwave" or the "Company"), a medical device aesthetic innovator in the non-invasive skin treatments, today announced the appointment of Assaf Korner as Chief Financial Officer, succeedingMichael Eden effective Septem...

2021-09-09 20:11 2738

PharmAbcine Announces Joint Patent Application with MSD for the Treatment of Cancer

DAEJEON, South Korea, Sept. 9, 2021 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of next-generation antibody therapeutics, today announced it submitted a Patent Cooperation Treaty (PCT) application for the combination therapy of...

2021-09-09 20:00 2408

Clover Biopharmaceuticals Receives Pharmaceutical Manufacturing Permit from Zhejiang Medical Products Administration to Produce COVID-19 Vaccine

CHENGDU, China, Sept. 9, 2021 /PRNewswire/ -- Clover Biopharmaceuticals, Ltd. (Clover) , a global clinical-stage biotechnology company developing novel vaccines and biologic therapeutic candidates, today announced that its wholly-owned subsidiary, Zhejiang Clover...

2021-09-09 19:51 3223

ABILITY Diabetes Global enrolls thousandth patient: A Cardinal Milestone Achieved

TAMPA, Fla., Sept. 9, 2021 /PRNewswire/ -- ABILITY Diabetes Global  (Randomized Comparison ofAbluminus DES+ Sirolimus-Eluting Stents versus Everolimus-Eluting Stents in Coronary Artery Disease Patients with Diabetes Mellit...

2021-09-09 19:26 4132

PAQ Therapeutics Announces Collaboration with Insilico Medicine to Develop Novel Therapies through Autophagy-Dependent Degradation

CAMBRIDGE, Mass., Sept. 9, 2021 /PRNewswire/ -- PAQ Therapeutics ("PAQ"), a biotechnology company harnessing the power of autophagy to restore health and cure disease, and Insilico Medicine ("Insilico"), an end-to-end artificial intelligence (AI)-driven drug discovery company, today announced tha...

2021-09-09 19:20 3237

Proximie Partners with Teladoc Health to Connect Operating Rooms Globally

Proximie software to be integrated in Teladoc Health's Solo™ platform ecosystem for hospitals and health systems, enabling an integrated experience for surgeons BOSTON, Sept. 9, 2021 /PRNewswire/ -- Proximie, a health technology platform focused on digitizing operating and diagnostic rooms, today...

2021-09-09 19:00 3589

AIA Live Returns For 2021: Helping People Live Healthier, Longer, Better Lives

HONG KONG, Sept. 9, 2021 /PRNewswire/ -- AIA's Global Ambassador David Beckham talks "Tai Chi" and mental health as he joins fellow AIA health and wellness ambassadors, industry experts and leading influencers from acrossAsia for AIA Live 2021. The inaugural AIA Live 2020, which streamed on AIA'...

2021-09-09 18:46 2923

China's Northernmost Free Trade Zone Sees Wider Reform and Opening-up

HARBIN, China, Sept. 9, 2021 /PRNewswire/ -- August 30 marks the second anniversary of the establishment of Harbin sub-area ofHeilongjiang pilot free trade zone (FTZ). Over the past two years, a total of 8,787 new enterprises have been established inHarbin sub-area. Nearly one-third of the enterp...

2021-09-09 18:12 2900

China's Northernmost Free Trade Zone Sees Wider Reform and Opening-up

HARBIN, China, Sept. 9, 2021 /PRNewswire/ -- August 30 marks the second anniversary of the establishment of Harbin sub-area ofHeilongjiang pilot free trade zone (FTZ). Over the past two years, a total of 8,787 new enterprises have been established inHarbin sub-area. Nearly one-third of the enterp...

2021-09-09 18:06 3066

Gan & Lee Pharmaceuticals to present data at the 57th Annual European Association for the Study of Diabetes Meeting

BEIJING and BRIDGEWATER, N. J., Sept. 9, 2021 /PRNewswire/ -- Gan & Lee Pharmaceuticals Co., Ltd. (hereinafter referred to as Gan & Lee, stock code: 603087.SH), is excited to present positive data from five abstracts which will be featured as short oral discussions at the 57th Annual European Ass...

2021-09-09 15:00 3342

B dot Medical Successfully Develops Compact Scanning Magnet for Proton Cancer Therapy System

TOKYO, Sept. 9, 2021 /PRNewswire/ -- B dot Medical Inc. has conducted an energization test of the scanning magnet, which is designed and manufactured at its factory, for a compact proton cancer therapy system under development, and confirmed the generation of a magnetic field. That means a major ...

2021-09-09 15:00 1971

Nanoform technology delivers successful results for Herantis CDNF drug candidate

HELSINKI, Sept. 9, 2021 /PRNewswire/ -- Nanoform Finland Plc ("Nanoform"), an innovative nanoparticle medicine enabling company, and Herantis Pharma Plc ("Herantis"), focusing on disease modifying therapies for debilitating neurodegenerative diseases based on the natural body protein CDNF (Cerebr...

2021-09-09 14:04 2086

Biokangtai: Recombinant COVID-19 Vaccine(Adenovirus Vector) licensed for manufacturing, which actively promotes vaccine export and improves vaccine accessibility

SHENZHEN, China, Sept. 8, 2021 /PRNewswire/ -- The other day Shenzhen Kangtai Biological Products Co., Ltd. announced that the company and AstraZeneca signed the "Amendment 1 to License Agreement". In addition to authorizing BIOKANGTAI to commercialize its Recombinant COVID-19 Vaccine(Adenovirus ...

2021-09-09 11:40 4536

WCLC 2021 | Mini Oral - Ascentage Pharma Announces Latest Data of Its Investigational Bcl-2/Bcl-xL Inhibitor Pelcitoclax (APG-1252) Combined with Osimertinib in Patients with EGFR TKI-Resistant Non-Small Cell Lung Cancer

SUZHOU, China, and ROCKVILLE, MD., Sept 9, 2021 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today reported the Phase Ib results of the dual Bcl-2/Bcl-xL inhi...

2021-09-09 08:26 7128
1 ... 629630631632633634635 ... 647